Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Chronic Candidal Meningitis: An Uncommon Manifestation of Candidiasis
1994
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis
2002 Standout
Combination and Sequential Antifungal Therapy for Invasive Aspergillosis: Review of Published In Vitro and In Vivo Interactions and 6281 Clinical Cases from 1966 to 2001
2003
Fluconazole Penetration into Cerebrospinal Fluid: Implications for Treating Fungal Infections of the Central Nervous System
1988
Antifungal Agents in the 1990s
1997
Itraconazole as maintenance treatment for cryptococcal meningitis in the acquired immune deficiency syndrome
1988
Spectrum of Cryptococcus neoformans Infection in 68 Patients Infected with Human Immunodificiency Virus
1990
Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions
2000
Infections withCryptococcus neoformansin the Acquired Immunodeficiency Syndrome
1989
Opportunistic Mycoses in the Immunocompromised Host: Experience at a Cancer Center and Review
1992
FUNGAL INFECTIONS OF THE CENTRAL NERVOUS SYSTEM
1999
Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patients
1994
Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis
2003 Standout
Toward more effective antifungal therapy: the prospects of combination therapy
2004
Adverse Drug Reactions to Systemic Antifungals Prevention and Management
1992
Cryptococcal Pneumonia Complicating Pregnancy
1998
Measurement of Cryptococcal Antigen in Serum and Cerebrospinal Fluid: Value in the Management of AIDS-Associated Cryptococcal Meningitis
1994
Sphingolipids and their metabolism in physiology and disease
2017 Standout
Systemically Administered Antifungal Agents
1992
Central Nervous System Infections in Heart and Heart-Lung Transplant Recipients
1989
Evolving Role of Flucytosine in Immunocompromised Patients: New Insights into Safety, Pharmacokinetics, and Antifungal Therapy
1992
Cryptococcal Skeletal Infections: Case Report and Review
1990
Fluconazole Compared with Amphotericin B plus Flucytosine for Cryptococcal Meningitis in AIDS
1990
Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility Testing
1996
Fluconazole monotherapy for cryptococcosis in non-AIDS patients
1996
Correlation of In Vitro Azole Susceptibility with In Vivo Response in a Murine Model of Cryptococcal Meningitis
1993
Fluconazole improves survival in septic shock: A randomized double-blind prospective study
2003
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Persistent Cryptococcus neoformans Infection of the Prostate after Successful Treatment of Meningitis
1989
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Fluconazole Combined with Flucytosine for Treatment of Cryptococcal Meningitis in Patients with AIDS
1994
Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis
2008
Comparison of Amphotericin B with Fluconazole in the Treatment of Acute AIDS-Associated Cryptococcal Meningitis
1992
Modern Synthetic Methods for Copper‐Mediated C(aryl)O, C(aryl)N, and C(aryl)S Bond Formation
2003 Standout
The value of serum cryptococcal antigen in the diagnosis of cryptococcal infection in patients infected with the human immunodeficiency virus
1990
Echinocandin antifungal drugs
2003 Standout
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
High-Dose Fluconazole for Treatment of Cryptococcal Disease in Patients with Human Immunodeficiency Virus Infection
1994
Combination therapy in a model of pulmonary aspergillosis
1991
Opportunistic Fungi: A View to the Future
2010
Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates
1990
Oral Azole Drugs as Systemic Antifungal Therapy
1994
Cryptococcosis in Human Immunodeficiency Virus–Negative Patients in the Era of Effective Azole Therapy
2001
Comparison of the Efficacy of Amphotericin B and Fluconazole in the Treatment of Cryptococcosis in Human Immunodeficiency Virus-Negative Patients: Retrospective Analysis of 83 Cases
1996
Antifungal agents: An overview. Part II
1994
Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study
2007
British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections
2003
Cryptococcosis and Idiopathic CD4 Lymphocytopenia
2007
Antifungal Agents in Children
2005
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
1990 Standout
Treatment of Cryptococcal Meningitis with Combination Amphotericin B and Flucytosine for Four as Compared with Six Weeks
1987
Antifungal Agents. Part I. Amphotericin B Preparations and Flucytosine
1998
Do In Vitro Susceptibility Data Predict the Microbiologic Response to Amphotericin B? Results of a Prospective Study of Patients withCandidaFungemia
1998
Practice Guidelines for the Management of Cryptococcal Disease
2000 Standout
The Poor Prognosis of Central Nervous System Cryptococcosis among Nonimmunosuppressed Patients: A Call for Better Disease Recognition and Evaluation of Adjuncts to Antifungal Therapy
2006
Toxoplasmic Encephalitis in AIDS
1992 Standout
Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome
1997
Cryptococcosis in human immunodeficiency virus-infected children
1996
Immunity to fungal infections
2011 Standout
Pacemaker Endocarditis Due to Candida albicans: Case Report and Review
1997
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Amphotericin B: 30 Years of Clinical Experience
1990
Management of cryptococcosis in non-HIV-related patients
2004
Considerations in Control and Treatment of Nosocomial Infections Due to Multidrug‐ResistantAcinetobacter baumannii
2003
Topographic diversity of fungal and bacterial communities in human skin
2013 StandoutNature
FUNGAL INFECTIONS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME
1997
Newer combination antifungal therapies for invasive aspergillosis
2010
Cryptococcal Endophthalmitis: Case Report and Review
1992
Infection in Organ-Transplant Recipients
1998 Standout
Cryptococcosis
2002
Cryptococcal Disease of the CNS in Immunocompetent Hosts: Influence of Cryptococcal Variety on Clinical Manifestations and Outcome
1995
Management of Cryptococcosis
1993
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Probing the N-5 Region of the Indoloquinoline Alkaloid, Cryptolepine for Anticryptococcal Activity
1999
Recombinant Interferon‐γ1b as Adjunctive Therapy for AIDS‐Related Acute Cryptococcal Meningitis
2004
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Head and neck aspergillosis in patients undergoing bone marrow transplantation. Report of four cases and review of the literature
1986 StandoutNobel
Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis
1997
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Antifungal agents: An overview. Part I
1994
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Candida Infections of Medical Devices
2004 Standout
Combination Treatment of Invasive Fungal Infections
2005
Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis
1997
FUNGAL INFECTIONS IN SOLID ORGAN TRANSPLANT RECIPIENTS
1995
Aspergillosis in Four Renal Transplant Recipients
1972
Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir
1986
How do the polyene macrolide antibiotics affect the cellular membrane properties?
1986
Fluorescence ratio imaging of cytosolic free Na+ in individual fibroblasts and lymphocytes
1989 StandoutNobel
Efficacy of Amphotericin B in Combination with Flucytosine against Flucytosine-Susceptible or Flucytosine-Resistant Isolates of Cryptococcus neoformans during Disseminated Murine Cryptococcosis
2005
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
1986 StandoutScience
Penile cryptococcosis with review of mycotic infections of penis
1985
Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination
1979
Zygomycetes in Human Disease
2000 Standout
Failure of Ketoconazole in Cryptococcal Meningitis
1982
Cryptococcal infections in patients with acquired immune deficiency syndrome
1986
Chemistry and biology of the polyene macrolide antibiotics.
1973
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Current and Emerging Azole Antifungal Agents
1999 Standout
Combination Antifungal Therapy
2004
Intracranial infection in cardiac transplant recipients
1981
Cryptococcosis in the Acquired Immunodeficiency Syndrome
1985
Amphotericin B Pharmacokinetics in Humans
1978
Pulmonary Cryptococcosis and Cushing's Syndrome
1983
Strategies in the Treatment of Systemic Fungal Infections
1980
The AIDS dementia complex: I. Clinical features
1986 Standout
“Proving the null hypothesis” in clinical trials
1982
Zygomycosis of the Maxillary Sinus and Palate Caused by
1978
Itraconazole Therapy for Cryptococcal Meningitis and Cryptococcosis
1989
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans
1996
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
2008
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
The Evolution of Pulmonary Cryptococcosis
1981
Amphotericin B: current understanding of mechanisms of action
1990
Effects of antifungal agent combinations administered simultaneously and sequentially against Aspergillus fumigatus
1994
Clinical Pharmacokinetics of Systemic Antifungal Drugs
1983
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits
1986
Synergistic Interaction in Vitro with Use of Three Antibiotics Simultaneously against Pseudomonas maltophilia
1980
Mucormycosis-Changing Status
1973
Patterns of Amphotericin B Killing Kinetics against Seven Candida Species
2004
Comparison of commercial kits for detection of cryptococcal antigen
1994
Sphingolipids as Targets for Treatment of Fungal Infections
2016
Aspergillus fumigatusand Aspergillosis
1999 Standout
Nocardia species: host-parasite relationships
1994 Standout
Role of Serodiagnostic Tests and Skin Tests in the Diagnosis of Fungal Disease
1987
CONCURRENT HYDATID DISEASE AND CRYPTOCOCCOSIS IN A 16‐YEAR‐OLD GIRL
1981
Inhibition of RNA Synthesis as a Therapeutic Strategy against Aspergillus and Fusarium : Demonstration of In Vitro Synergy between Rifabutin and Amphotericin B
1998
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Antifungal Agents Useful in Therapy of Systemic Fungal Infections
1983
In Vitro Double and Triple Synergistic Activities of Polymyxin B, Imipenem, and Rifampin against Multidrug-Resistant Acinetobacter baumannii
2004
Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis
1987
In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism.
1986
Successful Treatment of Cerebral Cryptococcoma and Meningitis with Miconazole
1980
Production of the hexitol D-mannitol by Cryptococcus neoformans in vitro and in rabbits with experimental meningitis
1990
Treatment of Experimental Cryptococcal Meningitis with Amphotericin B, 5-Fluorocytosine, and Ketoconazole
1982
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Use of amphotericin B with azole antifungal drugs: what are we doing?
1995
Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literature
1985
Microbial Biofilms: from Ecology to Molecular Genetics
2000 Standout
Cryptococcal Intracerebral Mass Lesions
1981
Pharmacokinetics of Amphotericin B in Infants and Children
1987
Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis
1996
Pharmacokinetics and Pharmacodynamics of Antifungals
2006
Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis
1991
Clinical and roentgenographic features of nosocomial pulmonary disease due to Mycobacterium xenopi.
1981
Guidelines for Treatment of Candidiasis
2004 Standout
Combination of Amphotericin B with Flucytosine Is Active In Vitro against Flucytosine-Resistant Isolates of Cryptococcus neoformans
2006
Treatment options of invasive fungal infections in adults
2006
Detection of AIDS Virus in Macrophages in Brain Tissue from AIDS Patients with Encephalopathy
1986 StandoutScience
Infections of Prosthetic Heart Valves and Cardiac Pacemakers
1989
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
1998 Standout
Treatment of mycoses in cancer patients
1983
Aspergillosis in Chronic Granulomatous Disease: Therapeutic Considerations
1980
Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real‐life combo study
2013
Hidden Killers: Human Fungal Infections
2012 Standout
Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease
2008
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Distribution and Activity of Amphotericin B in Humans
1985
Cryptococcus neoformans-Meningoencephalitis und Mehrfachinfektionen bei AIDS
1989
Galleria mellonella as a Model System To Study Cryptococcus neoformans Pathogenesis
2005 Standout
Cloning, expression, and characterization of Cryptococcus neoformans dihydrofolate reductase.
1993
Amphotericin B Colloidal Dispersion Combined with Flucytosine with or without Fluconazole for Treatment of Murine Cryptococcal Meningitis
1998
Invasive fungal infections: a review of epidemiology and management options
2006
Works of Branch T. Fields being referenced
Effect of Rapid Intravenous Infusion on Serum Concentrations of Amphotericin B 1
1971
Ketoconazole, amphotericin B, and amphotericin B methyl ester: comparative in vitro and in vivo toxicological effects on neutrophil function
1981
Amphotericin B Serum Concentrations During Therapy
1970
Polymyxin B and Rifampin: New Regimen for Multiresistant Serratia marcescens Infections
1977
Amphotericin B Serum Concentrations During Therapy 1
1970
A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis
1979
Effect of Rapid Intravenous Infusion on Serum Concentrations of Amphotericin B
1971
Pulmonary disease caused by Mycobacterium xenopei and Histoplasma capsulatum. A case report.
1969
Interactions between human granulocytes and Blastomyces dermatitidis
1979